Biopharmaceutical Third-Party Logistics Global Market Report 2024

Description

Biopharmaceutical third-party logistics involves external partners or services that facilitate the provision of logistics services to pharmaceutical companies. These companies outsource their transportation needs to third-party providers as a cost-saving measure, and the lack of in-house capabilities significantly contributes to the growing trend of transportation outsourcing.

The primary categories of supply chains in biopharmaceutical third-party logistics are cold chain and non-cold chain. The cold chain specifically pertains to a supply chain that ensures temperature control throughout the transportation of products sensitive to temperature variations. Various services, including transportation, warehousing and storage, among others, are utilized by pharmaceutical and biopharmaceutical companies, medical device companies, hospitals and clinics, and other relevant entities.

The biopharmaceutical third-party logistics market research report is one of a series of new reports from The Business Research Company that provides biopharmaceutical third-party logistics market statistics, including biopharmaceutical third-party logistics industry global market size, regional shares, competitors with a biopharmaceutical third-party logistics market share, detailed biopharmaceutical third-party logistics market segments, market trends and opportunities, and any further data you may need to thrive in the biopharmaceutical third-party logistics industry. This biopharmaceutical third-party logistics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The biopharmaceutical third-party logistics market size has grown strongly in recent years. It will grow from $131.23 billion in 2023 to $140.68 billion in 2024 at a compound annual growth rate (CAGR) of 7.2%. The growth observed in the historical period can be attributed to the globalization of pharmaceutical supply chains, stringent regulatory requirements, an increase in biopharmaceuticals, and a focus on cold chain logistics.

The biopharmaceutical third-party logistics market size is expected to see strong growth in the next few years. It will grow to $184.35 billion in 2028 at a compound annual growth rate (CAGR) of 7.0%. The anticipated growth in the forecast period can be ascribed to the expansion of personalized medicine, the growth of biologics and biosimilars, the digitalization of the supply chain, the increasing complexity of regulatory compliance, and the impact of COVID-19. Major trends expected in the forecast period include the emergence of on-demand logistics solutions, a focus on sustainability in logistics, advancements in last-mile delivery solutions, the implementation of pharma serialization and traceability, and the development of autonomous logistics.

The anticipated rise in the outsourcing of logistics is expected to fuel the growth of the biopharmaceutical third-party logistics market. The practice of outsourcing logistics involves enlisting the services of a third party to manage some or all of a company's logistical activities. In the realm of biopharmaceutical third-party logistics, this trend is observed in the outsourcing of cryogenic supply chain management to logistics partners. As reported in a December 2021 survey by Gartner Inc., a US-based provider of technological research and consulting, approximately 66% of logistics leaders among 298 supply chain professionals in the US augmented their budget for logistics outsourcing in 2021. Furthermore, an estimated 74% anticipate a further increase within the next two years. Hence, the upward trajectory of outsourcing logistics is anticipated to drive the growth of the biopharmaceutical third-party logistics market.

The introduction of innovative biopharmaceutical products is expected to be a driving force behind the growth of the biopharmaceutical third-party logistics market. Innovative biopharmaceutical products encompass advanced therapeutic substances derived from biological sources, such as monoclonal antibodies or gene therapies. The biopharmaceutical third-party logistics market plays a pivotal role in facilitating the efficient launch of these products by offering streamlined supply chain solutions, ensuring timely and secure distribution, and supporting the intricate logistics associated with bringing these innovative therapies to market. As indicated by The IQVIA Institute for Human Data Science in February 2022, a total of 84 novel active substances were launched in 2021, representing a significant increase from the number launched five years prior. This surge in innovation underscores the resilience of the global biomedical system, showcasing sustained momentum in the speed of pharmaceutical research and development. Therefore, the introduction of innovative biopharmaceutical products is anticipated to drive the growth of the biopharmaceutical third-party logistics market.

Technological advancements stand out as a prominent trend gaining momentum in the biopharmaceutical third-party logistics market. Major companies within this market are strategically launching innovative products to fortify their market position and gain a competitive edge. For example, in November 2022, Celcius Logistics Solutions Pvt Ltd., an India-based logistics services provider, introduced Hyper-Local temperature-controlled delivery services designed for food and pharmaceutical orders. The company's last-mile solution, catering to smaller quantities, is available in nine cities across the country. The hyperlocal approach ensures optimal material quality during transportation by continuously monitoring temperatures in real-time at each stage of the delivery process.

Top players in the biopharmaceutical third-party logistics market are actively engaged in product launches, including the establishment of healthcare logistics sub-brands and the introduction of new temperature-sensitive solutions. These endeavors aim to provide comprehensive logistics solutions for healthcare and pharmaceutical companies, specifically addressing the transportation needs of temperature-sensitive pharma and biopharma products. A healthcare logistics sub-brand, coupled with a new temperature-sensitive solution, signifies a specialized branch within the healthcare logistics sector offering dedicated solutions for transporting items requiring precise temperature control. For instance, in April 2021, CEVA Logistics, a France-based global logistics and supply chain company, unveiled FORPATIENTS healthcare logistics sub-brand with a new temperature-sensitive solution. This initiative encompasses end-to-end healthcare logistics, compliance assurance, and global visibility, catering to the specific requirements of the biopharmaceutical third-party logistics market. The comprehensive service ensures secure and compliant storage and transportation of temperature-sensitive products, playing a crucial role in maintaining product quality and patient safety within the intricate logistics of the biopharmaceutical supply chain.

In March 2022, STG Logistics Inc., a US-based provider of optimized logistics and transportation services, successfully acquired the intermodal division of XPO Logistics Inc. for $710 million. This strategic move enhances STG Logistics' position in the containerized logistics industry, paving the way for further achievements. XPO Logistics Inc. is a US-based provider of asset-based less-than-truckload (LTL) freight transportation and third-party logistics, including biopharma logistics.

Major companies operating in the biopharmaceutical third-party logistics market report are McKesson Corporation, AmerisourceBergen Corporation, United Parcel Service of America Inc., FedEx Corporation, DHL International GmbH, Kuehne + Nagel International AG, SF Express Co Ltd., DB Schenker, CH Robinson Worldwide Inc., Nippon Express Group, Expeditors International of Washington Inc., Sinotrans Limited, XPO Logistics Inc., Kerry Logistics Network Limited, Bollore Logistics, Catalent Inc., Agility Logistics, Almac Group, VersaCold Logistics Services, Cryoport Inc., Agility Logistics Corp, Fisher Clinical Services, CEVA Logistics Inc., LifeScience Logistics, Cold Chain Technologies LLC, Langham Logistics, Airpharm Logistics, Express Courier International, Bio Pharma Logistics, PCI Pharma Services

North America was the largest region in the biopharmaceutical third party logistics market in 2023. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biopharmaceutical third-party logistics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the biopharmaceutical third-party logistics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The biopharmaceutical third-party logistics market consists of revenues earned by entities by providing biopharmaceutical third-party logistics such as domestic transportation management, international transportation management, and value-added warehousing and distribution. The market value includes the value of related goods sold by the service provider or included within the service offering. The market value includes the value of related goods sold by the service provider or included within the service offering. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biopharmaceutical Third-Party Logistics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on biopharmaceutical third-party logistics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for biopharmaceutical third-party logistics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The biopharmaceutical third-party logistics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

1) By Supply Chain: Cold Chain; Non-Cold Chain
2) By Service: Transportation; Warehousing And Storage; Other Services
3) By End-User: Pharmaceutical And Biopharmaceutical Companies; Medical Device Companies; Hospitals And Clinics; Other End-Users
Companies Mentioned: McKesson Corporation; AmerisourceBergen Corporation; United Parcel Service of America Inc.; FedEx Corporation; DHL International GmbH
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r14310

1. Executive Summary

2. Biopharmaceutical Third-Party Logistics Market Characteristics

3. Biopharmaceutical Third-Party Logistics Market Trends And Strategies

4. Biopharmaceutical Third-Party Logistics Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Biopharmaceutical Third-Party Logistics Market Size and Growth

5.1. Global Biopharmaceutical Third-Party Logistics Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Biopharmaceutical Third-Party Logistics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Biopharmaceutical Third-Party Logistics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Biopharmaceutical Third-Party Logistics Market Segmentation

6.1. Global Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Cold Chain
Non-Cold Chain
6.2. Global Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Transportation
Warehousing And Storage
Other Services
6.3. Global Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Pharmaceutical And Biopharmaceutical Companies
Medical Device Companies
Hospitals And Clinics
Other End-Users

7. Biopharmaceutical Third-Party Logistics Market Regional And Country Analysis

7.1. Global Biopharmaceutical Third-Party Logistics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Biopharmaceutical Third-Party Logistics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Biopharmaceutical Third-Party Logistics Market

8.1. Asia-Pacific Biopharmaceutical Third-Party Logistics Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Biopharmaceutical Third-Party Logistics Market

9.1. China Biopharmaceutical Third-Party Logistics Market Overview
9.2. China Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Biopharmaceutical Third-Party Logistics Market

10.1. India Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Biopharmaceutical Third-Party Logistics Market

11.1. Japan Biopharmaceutical Third-Party Logistics Market Overview
11.2. Japan Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Biopharmaceutical Third-Party Logistics Market

12.1. Australia Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Biopharmaceutical Third-Party Logistics Market

13.1. Indonesia Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Biopharmaceutical Third-Party Logistics Market

14.1. South Korea Biopharmaceutical Third-Party Logistics Market Overview
14.2. South Korea Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Biopharmaceutical Third-Party Logistics Market

15.1. Western Europe Biopharmaceutical Third-Party Logistics Market Overview
15.2. Western Europe Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Biopharmaceutical Third-Party Logistics Market

16.1. UK Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Biopharmaceutical Third-Party Logistics Market

17.1. Germany Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Biopharmaceutical Third-Party Logistics Market

18.1. France Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Biopharmaceutical Third-Party Logistics Market

19.1. Italy Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Biopharmaceutical Third-Party Logistics Market

20.1. Spain Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Biopharmaceutical Third-Party Logistics Market

21.1. Eastern Europe Biopharmaceutical Third-Party Logistics Market Overview
21.2. Eastern Europe Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Biopharmaceutical Third-Party Logistics Market

22.1. Russia Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Biopharmaceutical Third-Party Logistics Market

23.1. North America Biopharmaceutical Third-Party Logistics Market Overview
23.2. North America Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Biopharmaceutical Third-Party Logistics Market

24.1. USA Biopharmaceutical Third-Party Logistics Market Overview
24.2. USA Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Biopharmaceutical Third-Party Logistics Market

25.1. Canada Biopharmaceutical Third-Party Logistics Market Overview
25.2. Canada Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Biopharmaceutical Third-Party Logistics Market

26.1. South America Biopharmaceutical Third-Party Logistics Market Overview
26.2. South America Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Biopharmaceutical Third-Party Logistics Market

27.1. Brazil Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Biopharmaceutical Third-Party Logistics Market

28.1. Middle East Biopharmaceutical Third-Party Logistics Market Overview
28.2. Middle East Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Biopharmaceutical Third-Party Logistics Market

29.1. Africa Biopharmaceutical Third-Party Logistics Market Overview
29.2. Africa Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Biopharmaceutical Third-Party Logistics Market Competitive Landscape And Company Profiles

30.1. Biopharmaceutical Third-Party Logistics Market Competitive Landscape
30.2. Biopharmaceutical Third-Party Logistics Market Company Profiles
- 30.2.1. McKesson Corporation
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. AmerisourceBergen Corporation
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. United Parcel Service of America Inc.
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. FedEx Corporation
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. DHL International GmbH
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Biopharmaceutical Third-Party Logistics Market Other Major And Innovative Companies

31.1. Kuehne + Nagel International AG
31.2. SF Express Co Ltd.
31.3. DB Schenker
31.4. CH Robinson Worldwide Inc.
31.5. Nippon Express Group
31.6. Expeditors International of Washington Inc.
31.7. Sinotrans Limited
31.8. XPO Logistics Inc.
31.9. Kerry Logistics Network Limited
31.10. Bollore Logistics
31.11. Catalent Inc.
31.12. Agility Logistics
31.13. Almac Group
31.14. VersaCold Logistics Services
31.15. Cryoport Inc.

32. Global Biopharmaceutical Third-Party Logistics Market Competitive Benchmarking

33. Global Biopharmaceutical Third-Party Logistics Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Biopharmaceutical Third-Party Logistics Market

35. Biopharmaceutical Third-Party Logistics Market Future Outlook and Potential Analysis

35.1 Biopharmaceutical Third-Party Logistics Market In 2028 - Countries Offering Most New Opportunities
35.2 Biopharmaceutical Third-Party Logistics Market In 2028 - Segments Offering Most New Opportunities
35.3 Biopharmaceutical Third-Party Logistics Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer